Thank you for participating in the Geographic Atrophy (GA) clinical research studies. By completing these studies, we will learn more about GA and a possible treatment option that may benefit you and others in the future.
Geographic Atrophy is an advanced form of age-related macular degeneration. It is a progressive, irreversible condition of the eye that causes severe vision loss. GA damages the part of the eye that is responsible for sight in the center of your field of vision.
Caring for a loved one with GA can be challenging, but there are a variety of tools and resources available that can help ease the burden. Learn More ›
The purpose of these studies is to understand the effects of an investigational drug called lampalizumab in reducing the speed of GA progression. Currently, these two clinical research studies (Chroma and Spectri) have completed recruitment.